Skip to main content

Indications for Examining the Placenta

  • Chapter
  • First Online:
Book cover Pathology of the Placenta

Abstract

An appropriate placenta triage system has to balance evidence-based indications for examination with clinical demand and available resources. In case of unfavourable outcome, there is also a legal aspect of the placental examination that cannot always be anticipated at the time of triage. Clinical demand is assessed in partnership with obstetricians and neonatologists. Triage systems can give general direction but each case should be judged individually. This chapter gives practical recommendations based on the recent Royal College of Pathologists (RCPath) and older College of American Pathologists (CAP) guidelines of which placentas need to be examined. In general, the RCPath guideline include full examination of fewer placentas than the CAP guideline. The following examination categories are considered: (1) full gross and microscopic examination of the placenta; (2) full gross examination, samples embedded, but histology only reported on clinical demand; and (3) gross examination with no sections embedded for histology, with short-term placental storage, reporting only if further clinical demand emerges. We describe 16 groups of placenta submissions and categorize them as to what type of examination may be considered: stillbirth (antepartum or intrapartum); early, late or recurrent miscarriages; termination of pregnancy; unexpected admission to neonatal intensive care unit; severe fetal distress; prematurity; fetal growth restriction; hydrops; amniotic fluid infection; abruption; morbidly adherent placenta; gestational diabetes; maternal comorbidities; abnormally shaped placenta; macroscopically noted umbilical cord abnormalities; and twin placentas.

Guidance for examination of placentas from live born babies is complex. Local consensus between the clinicians and pathologists should be established for practice. The system we present in this chapter describes a practical example of how placental examination can work in a routine histopathology laboratory, with a conservative approach to resource utilization, in keeping with the more recent RCPath guideline. Local practices will need to be created and adhered to, based on a locally adapted guideline taking into account the department’s capacity, ensuring that all those placentas that require examination are examined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ptacek I, Sebire NJ, Man JA, Brownbill P, Heazell AE. Systematic review of placental pathology reported in association with stillbirth. Placenta. 2014;35:552–62.

    Article  CAS  Google Scholar 

  2. Cox P, Evans C. Tissue pathway for histopathological examination of the placenta. London: Royal College of Pathologists; 2017.

    Google Scholar 

  3. Hargitai B, Marton T, Cox PM. Best practice no 178. Examination of the human placenta. J Clin Pathol. 2004;57:785–92.

    Article  CAS  Google Scholar 

  4. Langston C, Kaplan C, Macpherson T, Manci E, Peevy K, Clark B, et al. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med. 1997;121:449–76.

    CAS  PubMed  Google Scholar 

  5. Roberts DJ. Perinatal pathology: practice suggestions for limited-resource settings. Arch Pathol Lab Med. 2013;137:775–81.

    Article  Google Scholar 

  6. Odibo I, Gehlot A, Ounpraseuth ST, Magann EF. Pathologic examination of the placenta and its clinical utility: a survey of obstetrics and gynecology providers. J Matern Fetal Neonatal Med. 2016;29:197–201.

    Article  Google Scholar 

  7. Paul M, Goodman S, Felix J, Lewis R, Hawkins M, Drey E. Early molar pregnancy: experience in a large abortion service. Contraception. 2010;81:150–6.

    Article  Google Scholar 

  8. Salafia CM, Vintzileos AM. Why all placentas should be examined by a pathologist in 1990. Am J Obstet Gynecol. 1990;163:1282–93.

    Article  CAS  Google Scholar 

  9. Kraus FT. Perinatal pathology, the placenta, and litigation. Hum Pathol. 2003;34:517–21. discussion 522–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beata Hargitai .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hargitai, B., Marton, T., Heerema-McKenney, A. (2019). Indications for Examining the Placenta. In: Khong, T., Mooney, E., Nikkels, P., Morgan, T., Gordijn, S. (eds) Pathology of the Placenta. Springer, Cham. https://doi.org/10.1007/978-3-319-97214-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97214-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-97213-8

  • Online ISBN: 978-3-319-97214-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics